Skip to main content
Livermore
Livermore
ZHEN

Biocryst Pharmaceuticals Inc

BCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000882796

No open-market purchases or sales by Biocryst Pharmaceuticals Inc insiders were filed in the last 90 days; 319 institutions reported holding it in 13F filings for Q2 2026, worth $2.61B in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Biocryst Pharmaceuticals Inc changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of BCRX: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders2423257+18
Shares174.4M20.0M173.1M+18.7M (+12.1%)
Value$1.08B$123.5M$1.32B+$361.3M (+37.9%)

3 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (52)

Institutions that held Biocryst Pharmaceuticals Inc at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to BCRX in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.20,915,971$159.0M0.00%
Jupiter Asset Management Ltd1,069,899$8.13M0.07%
First Trust Advisors LP593,466$4.51M0.00%
Arrowstreet Capital, Limited Partnership431,230$3.28M0.00%
Cinctive Capital Management LP273,959$2.08M0.12%
Qube Research & Technologies Ltd253,901$1.93M0.00%
Macquarie Group Ltd249,495$1.90M0.00%
Exome Asset Management LLC196,500$1.49M1.01%
SG Americas Securities, LLC158,921$1.21M0.00%
Crestline Management, LP149,785$1.14M0.06%
Semanteon Capital Management, LP149,576$1.14M0.77%
Federated Hermes, Inc.111,027$843.8K0.00%
Wellington Management Group LLP107,820$819.4K0.00%
AMH Equity Ltd100,000$760.0K1.00%
Lazard Asset Management LLC96,096$730.0K0.00%
Schroder Investment Management Group83,770$638.3K0.00%
Man Group plc61,473$467.2K0.00%
Alpha DNA Investment Management LLC58,898$447.6K0.24%
Intech Investment Management LLC54,237$412.2K0.00%
Dark Forest Capital Management LP49,376$375.3K0.05%
Corton Capital Inc.39,491$300.1K0.15%
Prelude Capital Management, LLC38,900$295.6K0.02%
Gotham Asset Management, LLC38,893$295.6K0.00%
Marshall Wace, LLP33,257$252.8K0.00%
Sherbrooke Park Advisers LLC27,494$209.0K0.05%
Rockefeller Capital Management L.P.26,400$200.6K0.00%
Savant Capital, LLC22,062$167.7K0.00%
HRT Financial LP20,044$152.0K0.00%
Caption Management, LLC20,000$152.0K0.02%
Shell Asset Management Co19,434$148.0K0.01%
Scotia Capital Inc.18,577$141.2K0.00%
Magnetar Financial LLC17,928$136.3K0.00%
Squarepoint Ops LLC14,152$107.6K0.00%
Acadian Asset Management LLC11,325$85.0K0.00%
Quantinno Capital Management LP10,731$81.6K0.00%
Mariner, LLC10,034$76.3K0.00%
Aster Capital Management (DIFC) Ltd3,638$27.6K0.01%
Quest Partners LLC3,160$24.0K0.00%
Coppell Advisory Solutions LLC2,750$21.0K0.00%
Capital Performance Advisors LLP1,512$11.5K0.00%
Macroview Investment Management LLC1,132$8.60K0.01%
Hillsdale Investment Management Inc.830$6.31K0.00%
True Wealth Design, LLC789$6.00K0.00%
Northwestern Mutual Wealth Management Co527$4.00K0.00%
Johnson Financial Group, Inc.465$3.53K0.00%
Clear Street Markets LLC412$3.00K0.00%
Quantbot Technologies LP371$2.82K0.00%
Sterling Capital Management LLC210$1.60K0.00%
Smartleaf Asset Management LLC180$1.37K0.00%
Cornerstone Planning Group LLC100$8120.00%
Allspring Global Investments Holdings, LLC101$7670.00%
Ronald Blue Trust, Inc.29$1790.00%

Sold out (34)

Institutions that held Biocryst Pharmaceuticals Inc at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of BCRX in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Cubist Systematic Strategies, LLC1,112,232$6.87M
Sarissa Capital Management LP1,094,168$6.76M
AlphaCentric Advisors LLC675,000$4.17M
Prosight Management, LP398,700$2.46M
Point72 Europe (London) LLP267,649$1.65M
Hudson Bay Capital Management LP180,000$1.11M
Seven Eight Capital, LP169,612$1.05M
Laurion Capital Management LP148,655$918.7K
Tudor Investment Corp Et Al103,002$636.6K
Point72 Asia (Singapore) Pte. Ltd.72,666$449.1K
GTS Securities LLC71,682$443.0K
Point72 (DIFC) Ltd66,564$411.4K
Martingale Asset Management L P54,055$334.1K
Toroso Investments, LLC49,755$307.5K
Bayesian Capital Management, LP43,200$267.0K
ELCO Management Co., LLC30,792$190.3K
Capstone Investment Advisors, LLC26,742$165.3K
Simplex Trading, LLC26,565$164.0K
Public Employees Retirement System of Ohio22,754$140.6K
Alpine Global Management, LLC20,071$124.0K
Headlands Technologies LLC16,750$103.5K
National Asset Management, Inc.13,000$80.3K
DRW Securities, LLC11,987$74.1K
JGP Global Gestao de Recursos Ltda.10,865$67.1K
Wolverine Trading, LLC10,609$65.6K
Envestnet Asset Management Inc10,335$63.9K
Pacer Advisors, Inc.2,649$16.4K
Oliver Lagore Vanvalin Investment Group1,180$7.29K
Optiver Holding B.V.936$5.78K
National Bank of Canada500$3.32K
Mather Group, LLC.355$1.80K
North Star Investment Management Corp.200$1.24K
Aspire Private Capital, LLC100$618
Innealta Capital, LLC70$433

Not filed for Q3 2024 yet (3)

Institutions that held Biocryst Pharmaceuticals Inc at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding BCRX in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.19,956,255$123.3M
Susquehanna Fundamental Investments, LLC30,176$186.5K
Institutional & Family Asset Management, LLC398$2.46K